CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology
Open Access
- 6 November 2024
- journal article
- Published by Elsevier in Kidney International Reports
- Vol. 10 (2) , 375-385
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label periodThe Lancet Diabetes & Endocrinology, 2022
- Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cellsiScience, 2022
- Bardet–Biedl syndrome: The pleiotropic role of the chaperonin‐like BBS6, 10, and 12 proteinsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl SyndromeKidney International Reports, 2020
- Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceKidney International, 2020
- Prevalence of hyperfiltration among US youth/young adults with overweight and obesity: A population‐based association studyObesity Science & Practice, 2019
- Meta‐analysis of genotype‐phenotype associations in Bardet‐Biedl syndrome uncovers differences among causative genesHuman Mutation, 2019
- Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damageJournal of Human Hypertension, 2013
- The importance of renal impairment in the natural history of bardet-biedl syndromeAmerican Journal of Kidney Diseases, 1996